When survival is a popularity contest: the heartbreak of crowdfunding healthcare

Heather Bellamy’s March appointment at the Queen Elizabeth hospital in King’s Lynn didn’t go well. She had been diagnosed with acute myeloid leukemia five years before, in December 2014; now, her doctor explained gently, she had run out of options on the NHS. Bellamy, 48, would be starting a chemotherapy drug called azacitidine that could extend her life expectancy from two months to six. Her doctor asked if she had a bucket list. “I felt crushed,she remembers.

Spotlight

Other News

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Dom Nicastro | April 03, 2020

Read More

Spotlight

Resources